BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11847879)

  • 1. [Early detection and follow-up of prostatic carcinoma. Responsibilities of the general practitioner].
    Keuler FU; Altwein JE
    MMW Fortschr Med; 2002 Jan; 144(1-2):32-6, 38. PubMed ID: 11847879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The general practitioner's part in the initiation of diagnostic procedures in prostate cancer].
    Braun KP; May M; Grassmel Y; Führer S; Hoschke B; Braun V
    Aktuelle Urol; 2008 Mar; 39(2):141-6. PubMed ID: 18379968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early detection of cancer of the prostate. Pros and cons].
    Hoesl CE; Altwein JE
    MMW Fortschr Med; 2005 Apr; 147(14):32, 34-6. PubMed ID: 15887681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potentially curable prostate cancer patient and the pathways leading to diagnosis and treatment.
    Gjengstø P; Eide J; Frugård J; Bakke A; Høisaeter PA
    Scand J Urol Nephrol; 2004; 38(1):15-8. PubMed ID: 15204421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prostate cancer screening using prostate-specific antigen (PSA) determinations in plasma. National Academy of Medicine].
    Bourel M; Ardaillou R;
    Bull Acad Natl Med; 2003; 187(5):985-95. PubMed ID: 14979060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.
    Lim LS; Sherin K;
    Am J Prev Med; 2008 Feb; 34(2):164-70. PubMed ID: 18201648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and treatment of early prostate cancer].
    Zhu G; Liu M; Wan B
    Zhonghua Nan Ke Xue; 2005 Sep; 11(9):693-6, 712. PubMed ID: 16209214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing prostate cancer - what GPs need to know.
    Frydenberg M; Wijesinha S
    Aust Fam Physician; 2007 May; 36(5):345-7. PubMed ID: 17492070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-control prostate cancer screening studies should not exclude subjects with lower urinary tract symptoms.
    Godley PA; Carpenter WR
    J Clin Epidemiol; 2007 Feb; 60(2):176-80. PubMed ID: 17208124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early outcomes of active surveillance for localized prostate cancer.
    Hardie C; Parker C; Norman A; Eeles R; Horwich A; Huddart R; Dearnaley D
    BJU Int; 2005 May; 95(7):956-60. PubMed ID: 15839912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of digital rectal examination and prostate specific antigen in early detection of prostate cancer.
    Galić J; Karner I; Cenan L; Tucak A; Hegedus I; Pasini J; Bilandzija-Peranović M; Mihaljević S
    Coll Antropol; 2003; 27 Suppl 1():61-6. PubMed ID: 12955893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mass screening for prostate cancer is the best approach to early diagnosis and treatment of prostate cancer].
    Zhao XJ; Kong XB; Wang WH
    Zhonghua Nan Ke Xue; 2003 Nov; 9(8):563-5, 568. PubMed ID: 14689882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen kinetics in localized and advanced prostate cancer.
    Fitzpatrick JM; Banu E; Oudard S
    BJU Int; 2009 Mar; 103(5):578-87. PubMed ID: 19210674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
    Jønler M; Eddy B; Poulsen J
    Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
    Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH
    Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [General practical survey of individual prostate cancer screening].
    Guy L; van de Steene E; Védrine N; Teissonnière M; Boiteux JP
    Prog Urol; 2008 Jan; 18(1):46-52. PubMed ID: 18342156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentially advanced malignancies detected by screening for prostate carcinoma after an interval of 4 years.
    Postma R; Roobol M; Schröder FH; van der Kwast TH
    Cancer; 2004 Mar; 100(5):968-75. PubMed ID: 14983492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [PSA: the difficult position of general practitioners between patients and urologists].
    Vincendeau S; Abi Moussa M; Manunta A; Patard JJ; Guillé F; Lobel B
    Prog Urol; 2003 Apr; 13(2):252-5. PubMed ID: 12765060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing level of prostate-specific antigen and prostate cancer risk factors among 193 men examined in screening procedure.
    Opalińska E; Michalak A; Stoma F; Latalski M; Goniewicz M
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):57-63. PubMed ID: 15323167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An experience of individual and early diagnosis of prostate cancer in a Tunisian centre].
    Khouaja K; Ben Sorba N; Bouslama A; Youssef A; Taher Mosbah A
    Prog Urol; 2005 Apr; 15(2):255-9. PubMed ID: 15999603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.